Skip to main content Help with accessibility Skip to main navigation

ICOSAPENT ETHYL capsules (Vazkepa®▼) with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 29 - Sep - 2022
Body System:
Green
ICOSAPENT ETHYL capsules (Vazkepa®▼) with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides

The Pan Mersey Area Prescribing Committee recommends the prescribing of ICOSAPENT ETHYL capsules (Vazkepa®▼) with statin therapy, for reducing the risk of cardiovascular events in people with raised triglycerides in accordance with NICE TA805.

NHS Cheshire and Merseyside APPROVED